Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Ionis scraps Alzheimer’s candidate for people with Down syndrome
The decision marks another setback for a group of patients who are both at higher risk for the disease and not served by currently approved therapies.
Darren Incorvaia
Feb 20, 2026 1:50pm
How Biohaven is keeping its 'feet to the fire'
Feb 20, 2026 10:30am
Fierce Pharma
Supreme Court steps in: Trump's emergency tariffs struck down
Feb 20, 2026 11:33am
Roche taps Aussie oncologist to lead research—Chutes & Ladders
Feb 20, 2026 8:30am
Grail stock craters as Galleri trial fails to hit endpoint
Feb 20, 2026 7:30am
Daiichi picks former Novartis CMO John Tsai to head up R&D
Feb 20, 2026 4:56am
More News
Candel glows with $100M RTW deal to fund cancer drug launch
Feb 20, 2026 4:04am
Novartis jettisons ph. 1 cancer candidate after 0% efficacy
Feb 19, 2026 2:45pm
Trump met with Makary before FDA’s Moderna walkback: report
Feb 19, 2026 11:30am
Fierce Biotech Fundraising Tracker '26: Altesa; Korsana & more
Feb 19, 2026 10:30am
See more stories